source
- Merck, Gilead report mixed outcomes in key lung cancer, HIV studiesTrodelvy's latest setback carries implications for a newly important Merck drug, while the success of a once-weekly HIV tablet could boost Gilead's main business.BioPharma Dive · 1mo ago↗ source
- Stealthy startup Treeline plans a reverse mergerLed by former Loxo Oncology CEO Josh Bilenker, the startup now has a trio of cancer drugs in early-stage testing and more following closely behind.BioPharma Dive · 1mo ago↗ source
- Trump administration warns more than 500 hospitals to provide more price information or face finesThe Trump administration has warned more than 500 hospitals that they are failing to provide the public with basic pricing information.STAT · 1mo ago